1. Home
  2. CNTB vs PETS Comparison

CNTB vs PETS Comparison

Compare CNTB & PETS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CNTB
  • PETS
  • Stock Information
  • Founded
  • CNTB 2012
  • PETS 1996
  • Country
  • CNTB United States
  • PETS United States
  • Employees
  • CNTB N/A
  • PETS N/A
  • Industry
  • CNTB Biotechnology: Pharmaceutical Preparations
  • PETS Retail-Drug Stores and Proprietary Stores
  • Sector
  • CNTB Health Care
  • PETS Consumer Staples
  • Exchange
  • CNTB Nasdaq
  • PETS Nasdaq
  • Market Cap
  • CNTB 68.5M
  • PETS 82.0M
  • IPO Year
  • CNTB 2021
  • PETS N/A
  • Fundamental
  • Price
  • CNTB $1.17
  • PETS $4.07
  • Analyst Decision
  • CNTB Strong Buy
  • PETS Sell
  • Analyst Count
  • CNTB 1
  • PETS 2
  • Target Price
  • CNTB $8.00
  • PETS $3.50
  • AVG Volume (30 Days)
  • CNTB 24.6K
  • PETS 182.6K
  • Earning Date
  • CNTB 09-05-2024
  • PETS 11-06-2024
  • Dividend Yield
  • CNTB N/A
  • PETS 29.41%
  • EPS Growth
  • CNTB N/A
  • PETS N/A
  • EPS
  • CNTB N/A
  • PETS N/A
  • Revenue
  • CNTB $24,116,000.00
  • PETS $270,772,000.00
  • Revenue This Year
  • CNTB N/A
  • PETS N/A
  • Revenue Next Year
  • CNTB $63.90
  • PETS $3.27
  • P/E Ratio
  • CNTB N/A
  • PETS N/A
  • Revenue Growth
  • CNTB N/A
  • PETS 2.26
  • 52 Week Low
  • CNTB $0.68
  • PETS $2.90
  • 52 Week High
  • CNTB $2.84
  • PETS $8.27
  • Technical
  • Relative Strength Index (RSI)
  • CNTB 44.02
  • PETS 56.76
  • Support Level
  • CNTB $1.18
  • PETS $3.78
  • Resistance Level
  • CNTB $1.26
  • PETS $4.17
  • Average True Range (ATR)
  • CNTB 0.07
  • PETS 0.18
  • MACD
  • CNTB -0.01
  • PETS -0.01
  • Stochastic Oscillator
  • CNTB 13.59
  • PETS 62.22

About CNTB Connect Biopharma Holdings Limited

Connect Biopharma Holdings Ltd is a clinical-stage company focused on the discovery and development of next-generation immune modulators for the treatment of serious autoimmune diseases and inflammation. It has leveraged its expertise in the biology of T cell modulation to build a portfolio of drug candidates consisting of small molecules and antibodies targeting critical pathways of inflammation. Its pipeline includes CBP-201, CBP-307 and CBP-174.

About PETS PetMed Express Inc.

PetMed Express Inc along with its subsidiaries is a nationwide pet pharmacy. The company markets prescription and non-prescription pet medications, health products, and supplies for dogs and cats, direct to the consumer. The company generates its revenue by selling pet medications and pet supplies mainly to retail consumers.

Share on Social Networks: